|
TWN Info Service on Intellectual
Property Issues (Nov07/02)
2 November 2007
TRIPS: LDCS JOIN CALL FOR TRIPS DISCLOSURE REQUIREMENTS
Published in SUNS #6352 dated 26 October 2007
The WTO’s TRIPS Council held a meeting on 23-24 Oct 2007. Below is a
report of that meeting.
The following article is reproduced here with the permission of the
South North Development Monitor (SUNS). Any reproduction or re-circulation
requires permission of the SUNS (sunstwn@bluewin.ch).
With best wishes
Martin Khor
TWN
-----------------------------------------------------
TRADE: LDCS JOIN CALL FOR TRIPS DISCLOSURE REQUIREMENTS
Geneva, 25 Oct 2007: By Kanaga Raja
The least developed countries have joined a proposal co-sponsored by
many developing countries that calls for the TRIPS Agreement to be amended
so that patent applicants have to disclose the origin of genetic resources
and/or associated traditional knowledge used in their inventions.
Lesotho,
speaking on behalf of the least developed countries, made this announcement
Wednesday at a formal meeting (23-24 October) of the TRIPS Council.
Earlier Tuesday, the first day of the two-day meeting, the TRIPS Council
agreed to extend the deadline by two years for countries to accept an
amendment to provisions on pharmaceutical patents that would make it
easier for poorer countries to obtain cheaper generic versions of patented
medicines (see below).
The two-day meeting also discussed issues relating to China's transitional
review mechanism, enforcement, and technology transfer and technical
cooperation.
According to trade officials, on the issue of enforcement, several developing
countries voiced concerns about discussing this issue and insisted that
this not be a regular agenda item.
On the TRIPS/Convention on Biological Diversity issue, the least developed
countries have now joined the African Group (represented by Uganda) as well as individual countries that include
Brazil, China, Colombia,
Cuba, India, Pakistan,
Peru, Thailand, Tanzania,
South Africa, Ecuador, Venezuela
and Paraguay
as co-sponsors of the proposal outlined in document IP/C/W/474.
The issue of disclosure of origin of genetic resources is being discussed
outside the TRIPS Council by some of the major players that include
India, Brazil
and the European Union as part of the Doha
negotiations. According to diplomatic sources, the developing countries
are insisting that a satisfactory solution to this issue has to be part
of a Doha deal.
The proposal co-sponsored by the developing countries said that the
relationship between the TRIPS Agreement and the Convention on Biological
Diversity (CBD) is an outstanding implementation issue.
In addition to the intensive technical work in the TRIPS Council, the
Director-General has undertaken dedicated consultations through his
Friends, including more recently through Mr. Rufus Yerxa, Deputy Director-General,
it added.
The proposal noted that there have been extensive discussions in these
processes on the introduction into the TRIPS Agreement of a mandatory
requirement for the disclosure of origin of biological resources and/or
associated traditional knowledge used in inventions for which intellectual
property rights are applied for.
The proposal has outlined text in the form of Article 29bis on disclosure
of origin of biological resources and/or associated traditional knowledge.
The proposed text said that where the subject matter of a patent application
concerns, is derived from or developed with biological resources and/or
associated traditional knowledge, Members shall require applicants to
disclose the country providing the resources and/or associated traditional
knowledge, from whom in the providing country they were obtained, and,
as known after reasonable inquiry, the country of origin.
Members shall also require that applicants provide information including
evidence of compliance with the applicable legal requirements in the
providing country for prior informed consent for access and fair and
equitable benefit-sharing arising from the commercial or other utilization
of such resources and/or associated traditional knowledge.
It added that Members shall publish the information disclosed jointly
with the application or grant, whichever is made first. It also said
that Members shall put in place effective enforcement procedures so
as to ensure compliance with the obligations set out in this Article.
In particular, Members shall ensure that administrative and/or judicial
authorities have the authority to prevent the further processing of
an application or the grant of a patent and to revoke, subject to the
provisions of Article 32 of the TRIPS Agreement, or render unenforceable
a patent when the applicant has, knowingly or with reasonable grounds
to know, failed to comply with the obligations of this Article or provided
false or fraudulent information.
According to trade officials, positions remained unchanged on this subject.
Brazil
however indicated that it and other members are exploring some flexibility
in their positions on the key "implementation" issues and
related subjects - biodiversity/traditional knowledge, the extension
of the higher level of protection for geographical indications beyond
wines and spirits, and the multilateral register for wines and spirits.
However, said Brazil,
this would depend on the priority issues of agriculture and non-agricultural
market access.
Peru
presented its latest paper on its experience in trying to track down
bio-piracy (IP/C/W/493). According to trade officials, the paper offers
some background data on Peru's
genetic and demographic diversity, describes how it tries to track down
instances of bio-piracy and gives examples of challenges to "bad"
patents in various countries where Peruvian materials (or materials
available in Peru)
were involved.
Japan
presented a proposal for setting up databases of traditional knowledge
to help patent examiners decide whether an invention uses existing traditional
knowledge and therefore avoiding "bad" patenting. Access to
the databases would be restricted only to computers with specific Internet
protocol (IP) addresses.
On Tuesday, the TRIPS Council agreed to extend the deadline by two years
for countries to accept an amendment to provisions on pharmaceutical
patents that would make it easier for poorer countries to obtain cheaper
generic versions of patented medicines.
The original deadline of 31 December 2007 has now been extended to 31
December 2009.
According to trade officials, the decision still has to be confirmed
when the General Council meets in December, but this is likely to be
a mere formality.
Trade officials said that the deadline for ratifying the amendment was
extended because so far only 11 countries have accepted the amendment
(two-thirds of the membership have to accept before the amendment takes
effect).
(The members that have accepted are the United
States, Switzerland,
El Salvador, Korea, Norway,
India, Philippines, Israel,
Japan, Australia, and Singapore.)
According to trade officials, the EU said that the European Council
of Ministers should approve the acceptance soon.
The African Group (Uganda
speaking) urged members to agree to the two-year extension and said
that its members will be able to accept the amendment "sooner rather
than later."
Canada and Rwanda reported
on the first compulsory license issued under the waiver.
Canada said that
it received a request from a generic manufacturer, Apotex, on 4 September
and the compulsory license - which allows Apotex to produce the generic
version without the permission of the patent owner and to export it
to Rwanda
- was issued on 19 September.
The license is valid for two years, with the possibility of extending
for another two years if the approved quantity of 260,000 has not all
been exported by then, Canada
said.
The medicine is TriAvir, a fixed-dose combination product of Zidovudine,
Lamivudine and Nevirapine.
According to trade officials, Canada
said that it has completed a review of its revised law and the experience
of issuing a compulsory license.
The report should be finished soon and Canada said that it hopes to present
it at the next TRIPS Council meeting. It added that the waiver (agreed
in 2003) and amendment are not the only tool for helping poorer countries
acquire cheaper medicines. Canada said that it is working on
tax incentives as another way of achieving this.
China said that it
would appreciate countries presenting information on the lessons they
have learned, as Canada
had promised, because this would help other countries change their own
laws.
Switzerland
said that its Parliament passed revised laws in June, and these will
take effect in "early 2008".
Trade officials said that previously, Norway,
Canada, India and the
EU formally informed the TRIPS Council that they had changed their laws.
With regards to China's
transitional review mechanism, trade officials said that China described
in detail the "impressive" actions it has taken to strengthen
intellectual property protection - some of this highlighted in its document
IP/C/W/505.
It also replied at length to most of the questions asked by Japan, the US and EU (documents IP/C/W/498, 502
and 503). According to trade officials, it however declined to answer
some of the questions on the grounds that these were related to a current
dispute.
Trade officials said that Japan,
the US and EU recognized
China's efforts
but voiced concerns about an increase in piracy and counterfeiting.
The US and EU said that over 80% of counterfeits they
seized were from China,
although Chinese piracy has declined in some areas - the US mentioned software
piracy.
On the issue of enforcement, trade officials said that this was on the
agenda because Japan
wanted to introduce its new paper. However, Brazil,
China, Argentina and India reiterated their concerns over
discussing this issue and continued to insist that it is not a regular
agenda item.
According to trade officials, Japan's
paper (IP/C/W/501) focuses on its customs seizures. Increasingly, counterfeited
products arrive in smaller packages - particularly by post, which Japan partly attributed
to the development of electronic commerce - and described as for "personal
use".
Japan
said that it has responded by focussing more on personal-use items,
and by strengthening information on databases, the customs' internal
Intranet, and training.
According to trade officials, the US,
Chinese Taipei, Canada,
the EU and Switzerland
appreciated Japan's
information - some of them expressing an interest in the reference to
e-commerce and the use of the Intranet. They defended discussing this
issue in the TRIPS Council.
Brazil said that the Council's mandate on discussing enforcement should
be on whether and how countries are complying with enforcement provisions
written into the TRIPS Agreement, and not on what it called "trade
measures at the border".
According to trade officials, Brazil then went through the TRIPS section
on enforcement, provision by provision, and asked how Japan was complying
with the many requirements (such as to ensure that the procedure is
fair and equitable, that there are no undue delays, that accused parties
have a fair hearing and are allowed judicial review).
Japan said that it
would reply to Brazil
later.
With respect to Art. 66.2 of the TRIPS Agreement (developed countries
reporting on how they meet the requirement to provide incentives to
their companies and institutions to transfer technology to least-developed
countries) and Art. 67 (on technical cooperation), reports on both had
been supplied by Switzerland, Japan, the EU and some of its members,
New Zealand, Norway, the US and Australia.
Sierra Leone and
Uganda also presented
papers on their needs for technical cooperation. According to trade
officials, this made them the first two least-developed countries to
do so under the TRIPS Council's 2005 decision to allow least-developed
countries until 1 July 2013 to implement the TRIPS Agreement.
The decision includes provisions for "enhanced technical cooperation"
for these countries and says: "With a view to facilitating targeted
technical and financial cooperation programmes, all the least-developed
country Members will provide to the Council for TRIPS, preferably by
1 January 2008, as much information as possible on their individual
priority needs for technical and financial cooperation in order to assist
them taking steps necessary to implement the TRIPS Agreement."
Trade officials said that the US, EU and Egypt welcomed the two countries'
papers and urged others to do the same. The EU hoped that by the next
meeting, more papers would be available so that the Council could discuss
the issues in depth.
According to trade officials, Brazil
went through a large number of items in several reports from developed
countries and argued that they were too long and complicated, and inappropriate
for the two articles.
For example, Brazil
questioned whether some assistance is truly for technology transfer
under Art. 66.2 and whether "harmonizing" intellectual property
laws is appropriate for Art. 67 when the TRIPS Agreement says that countries
are free to choose how to protect intellectual property in their own
ways.
Trade officials said that Brazil, China and India raised concerns particularly
over sections supplied by the European Patent Office for the EU's report
on technical cooperation, which they described as un-factual, erroneous,
subjective and patronizing.
On the other hand, developed countries defended their reports.
Chairperson Ambassador Yonov Agah of Nigeria
reported that members remain deadlocked over whether to make the secretariat
of the Convention on Biological Diversity (CBD) an observer in the TRIPS
Council.
According to trade officials, Brazil
and Egypt
said that this was illogical since the CBD is more directly concerned
in some of the Council's work than some existing observers. Brazil urged the Chair to provide
more information on who objects and why at the next meeting.
The next meeting of the TRIPS Council is scheduled for 26-27 February
2008.
BACK
TO MAIN | ONLINE
BOOKSTORE | HOW TO ORDER
|